Literature DB >> 19796793

Expression of apolipoprotein M in human hepatocellular carcinoma tissues.

Jingting Jiang1, Changping Wu, Guanghua Luo, Lu Zheng, Lujun Chen, Xiaoying Zhang, Ning Xu.   

Abstract

The present study examined mRNA levels and protein mass of apolipoprotein M (apoM) in human hepatocellular carcinoma (HCC) tissues and in the adjacent tissues. Plasma apoM levels in these HCC patients were also determined and compared to the normal subjects. The mean level of plasma apoM in the HCC patients was 0.61±0.30ODmm⁻², which was significantly higher than that in the normal subjects 0.37±0.07ODmm⁻² (P<0.01). However, both apoM mRNA levels and apoM protein mass in the HCC tissues were significantly lower than in the adjacent tissues (P<0.05). It is concluded that human hepatocellular carcinoma tissues had a reduced capacity to produce apoM than the adjacent non-tumor tissues. However, the plasma apoM levels were higher in the HCC patients than in normal subjects, which suggested that tissues adjacent to the tumors or extra-hepatic apoM production in the HCC patients may contribute to the higher plasma apoM levels in these patients. The clinical significance of apoM in relation to HCC still needs further investigation.
Copyright © 2009. Published by Elsevier GmbH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19796793     DOI: 10.1016/j.acthis.2009.08.005

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  9 in total

1.  ApoM regulates PFKL through the transcription factor SREBF1 to inhibit the proliferation, migration and metastasis of liver cancer cells.

Authors:  Xiao Zhang; Yaping Bai; Wenhao Zhu; Xinyue Lv; Wenjun Pei
Journal:  Oncol Lett       Date:  2022-05-16       Impact factor: 3.111

2.  Expression and localization of apolipoprotein M in human colorectal tissues.

Authors:  Guanghua Luo; Xiaoying Zhang; Qinfeng Mu; Lujun Chen; Lu Zheng; Jiang Wei; Maria Berggren-Söderlund; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2010-09-16       Impact factor: 3.876

3.  Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replication.

Authors:  Jin-Gang Gu; Cheng-liang Zhu; Duo-zhi Cheng; Yan Xie; Fang Liu; Xin Zhou
Journal:  Lipids Health Dis       Date:  2011-08-29       Impact factor: 3.876

4.  TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells.

Authors:  Chunhua Zhu; Dongmei Di; Xiaoying Zhang; Guanghua Luo; Zongchun Wang; Jiang Wei; Yuanping Shi; Maria Berggren-Söderlund; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2011-11-04       Impact factor: 3.876

5.  Positive association between serum apolipoprotein M levels and hepatitis B virus DNA load in HBeAg-negative chronic hepatitis B.

Authors:  Ting Shen; Wei Min Wu; Wen Han Du; Lin Wang; La Gu He; Li Tan; ZeYou Wang; Ruohong Chen; Min Hu; Ya Ping Ren
Journal:  Lipids Health Dis       Date:  2016-12-07       Impact factor: 3.876

6.  Apolipoprotein M could inhibit growth and metastasis of SMMC7721 cells via vitamin D receptor signaling.

Authors:  Miaomei Yu; Lili Pan; Chen Sang; Qinfeng Mu; Lu Zheng; Guanghua Luo; Ning Xu
Journal:  Cancer Manag Res       Date:  2019-04-30       Impact factor: 3.989

Review 7.  Apolipoproteins and cancer.

Authors:  Liwen Ren; Jie Yi; Wan Li; Xiangjin Zheng; Jinyi Liu; Jinhua Wang; Guanhua Du
Journal:  Cancer Med       Date:  2019-10-01       Impact factor: 4.452

8.  Construction of 2DE Patterns of Plasma Proteins: Aspect of Potential Tumor Markers.

Authors:  Stanislav Naryzhny; Natalia Ronzhina; Elena Zorina; Fedor Kabachenko; Nikolay Klopov; Victor Zgoda
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

Review 9.  Apolipoprotein: prospective biomarkers in digestive tract cancer.

Authors:  Yibo Zhang; Lu Zheng
Journal:  Transl Cancer Res       Date:  2020-05       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.